Literature DB >> 11688851

Cryopreservation of suckling pig hepatocytes.

Z Chen1, Y Ding, H Zhang.   

Abstract

To determine the best and simplest method for cryopreservation of pig hepatocytes, we compared immediate cryopreservation with cryopreservation after short-term culture. Suckling pig hepatocytes were isolated by a modified 2-step in situ collagenase perfusion method, suspended in serum-free medium, and preserved for 10 da by two cryopreservation methods. Serial measurements were made of cell viability, LDH release, synthesis of protein, urea and glucose, glucose-6-phosphatase (G-6-Pase) activity, and diazepam transformation after thawing. These measurements were performed on both groups of cultured hepatocytes, and on freshly isolated hepatocytes, which served as a control. High viability (>95%)of thawed hepatocytes was obtained and maintained in both cryopreservation groups. There were no significant differences in cell viability, protein synthesis, glucose synthesis, G-6-Pase activity, or diazepam transformation between the two cryopreservation groups. In the immediate cryopreservation group, urea synthesis was less than in the group with cryopreservation after short-term culture. Protein synthesis, glucose synthesis, and diazepam transformation were lower in both cryopreserved groups than in the controls. The results showed that a protocol of immediate cryopreservation of hepatocytes in RPMI-1640 medium containing 10% DMSO, hormones, growth factors, and 10% newborn bovine serum, together with rate-controlled freezing and rapid thawing, provides indices of cell viability and function during subsequent serum-free culture that are comparable to hepatocytes cryopreserved after short-term culture, except for lower urea production. This simple procedure can be used in studies of bioartificial liver and hepatocyte transplantation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11688851

Source DB:  PubMed          Journal:  Ann Clin Lab Sci        ISSN: 0091-7370            Impact factor:   1.256


  8 in total

1.  The development of a new bioartificial liver and its application in 12 acute liver failure patients.

Authors:  Yi-Tao Ding; Yu-Dong Qiu; Zhong Chen; Qing-Xiang Xu; He-Yuan Zhang; Qing Tang; De-Cai Yu
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Response of porcine hepatocytes in primary culture to plasma from severe viral hepatitis patients.

Authors:  Yong-Bo Cheng; Ying-Jie Wang; Shi-Chang Zhang; Jun Liu; Zhi Chen; Jia-Jia Li
Journal:  World J Gastroenterol       Date:  2005-12-28       Impact factor: 5.742

Review 3.  Hepatocyte cryopreservation: is it time to change the strategy?

Authors:  Xavier Stéphenne; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2010-01-07       Impact factor: 5.742

4.  Cryopreservation of isolated primary rat hepatocytes: enhanced survival and long-term hepatospecific function.

Authors:  Meindert N Sosef; John M Baust; Keishi Sugimachi; Alex Fowler; Ronald G Tompkins; Mehmet Toner
Journal:  Ann Surg       Date:  2005-01       Impact factor: 12.969

5.  Functional evaluation of a new bioartificial liver system in vitro and in vitro.

Authors:  Zhong Chen; Yi-Tao Ding
Journal:  World J Gastroenterol       Date:  2006-02-28       Impact factor: 5.742

Review 6.  Clinical application of bioartificial liver support systems.

Authors:  Maarten Paul van de Kerkhove; Ruurdtje Hoekstra; Robert A F M Chamuleau; Thomas M van Gulik
Journal:  Ann Surg       Date:  2004-08       Impact factor: 12.969

7.  Transplantation of porcine hepatocytes cultured with polylactic Acid-o-carboxymethylated chitosan nanoparticles promotes liver regeneration in acute liver failure rats.

Authors:  Zhong Chen; Renan Chang; Weijun Guan; Hongyu Cai; Fei Tang; Wencai Zhu; Jiahui Chen
Journal:  J Drug Deliv       Date:  2011-03-30

8.  A technique for lyopreservation of Clostridium ljungdahlii in a biocomposite matrix for CO absorption.

Authors:  Mark J Schulte; Jason Solocinski; Mian Wang; Michelle Kovacs; Ryan Kilgore; Quinn Osgood; Lukas Underwood; Michael C Flickinger; Nilay Chakraborty
Journal:  PLoS One       Date:  2017-07-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.